Daugaliyeva Aida Tlekovna | Genomic Data Analytics | Best Researcher Award

Posted on by ScienceFather

Dr. Daugaliyeva Aida Tlekovna | Genomic Data Analytics | Best Researcher Award

Kazakh Research Institute of Livestock and Fodder Production | Kazakhstan

PUBLICATION PROFILE

Scopus

Orcid

INTRODUCTION ๐ŸŒŸ

Dr. Daugaliyeva Aida Tlekovna is a prominent figure in the field of veterinary sciences, hailing from Kazakhstan, specifically Almaty. With her extensive experience in veterinary research and expertise in molecular genetics, she has significantly contributed to the understanding and management of animal diseases. Aida Tlekovna holds the title of Candidate of Veterinary Sciences and serves as an Associate Professor, blending academic prowess with hands-on research. Her work continues to shape veterinary science in Kazakhstan and beyond.

EARLY ACADEMIC PURSUITS ๐ŸŽ“

Born in 1979, Dr. Daugaliyeva began her academic journey in the field of veterinary sciences. Her early education and studies set the foundation for her later contributions in molecular genetics, microbiology, and veterinary research. Over the years, she became deeply involved in research initiatives that would shape her career and lead to various leadership roles in prominent institutions.

PROFESSIONAL ENDEAVORS ๐Ÿ’ผ

Dr. Aida Daugaliyevaโ€™s career spans multiple prestigious institutions in Kazakhstan. She has been a significant part of the Kazakh Research Institute of Livestock and Fodder Production since March 2013. Her prior experience includes serving as a Leading Researcher and Head of various laboratories at the Kazakh Research Veterinary Institute in Almaty. Dr. Daugaliyeva has held positions focused on epizootiology, molecular genetics, biochemistry, immunology, and the development of biological products. These roles underscore her commitment to advancing research in veterinary science.

CONTRIBUTIONS AND RESEARCH FOCUS ๐Ÿ”ฌ

Dr. Daugaliyevaโ€™s research has focused extensively on the molecular genetics of microorganisms, with an emphasis on understanding bacterial diseases in livestock. Her work on epizootological monitoring and risk assessment has played a crucial role in improving the veterinary care of animals in Kazakhstan. As Head of the Laboratory of Molecular Genetics of Microorganisms, Biochemistry, and Immunology, she has advanced our understanding of animal diseases at a genetic and molecular level.

IMPACT AND INFLUENCE ๐ŸŒ

Dr. Daugaliyeva has had a substantial influence on veterinary science in Kazakhstan. Through her leadership roles, she has inspired a generation of researchers and practitioners dedicated to improving livestock health. Her work in risk assessment and disease management has contributed to a better understanding of zoonotic diseases, especially bacterial infections, which have a direct impact on public health and food security.

ACADEMIC CITATIONS AND PUBLICATIONS ๐Ÿ“š

Dr. Daugaliyeva has a notable body of work in veterinary science, particularly in molecular genetics and immunology. Her research is well-regarded in scientific communities, and she has been cited in numerous academic papers related to animal health, disease control, and genetics. Her publications have contributed to shaping best practices in veterinary medicine, especially in the context of bacterial diseases.

HONORS & AWARDS ๐Ÿ…

Throughout her career, Dr. Daugaliyeva has received recognition for her excellence in veterinary science. Her contributions to molecular genetics and animal health research have earned her various honors and awards within the academic and professional circles. These accolades reflect her dedication and hard work in advancing veterinary practices and scientific discovery.

LEGACY AND FUTURE CONTRIBUTIONS ๐ŸŒฑ

Dr. Aida Tlekovna’s legacy in veterinary science is one marked by continuous innovation and dedication. She has laid a solid foundation for future research in the field of veterinary microbiology and animal health. As she continues her work, Dr. Daugaliyeva is poised to make further contributions, particularly in the areas of disease prevention and the development of new biological products.

FINAL NOTE โœจ

Dr. Aida Daugaliyevaโ€™s journey from a young academic to a leader in veterinary research showcases her unwavering commitment to animal health and scientific advancement. Her career serves as an inspiration for current and future researchers in the field of veterinary science. With her continued dedication and expertise, she will undoubtedly shape the future of veterinary care in Kazakhstan and globally.

TOP NOTES PUBLICATIONSย ๐Ÿ“šย 

STUDY OF MOLECULAR VIRULENCE FACTORS OF BRUCELLA ISOLATES FOR VACCINE DEVELOPMENT

    • Authors: ะ.ะข. Daugaliyeva, S.ะข. Daugaliyeva, N.S. Kydyr, S.A. Orazgaliyev, S. PELETTO

    • Journal: ะœะ˜ะšะ ะžะ‘ะ˜ะžะ›ะžะ“ะ˜ะฏ ะ–ำ˜ะะ• ะ’ะ˜ะ ะฃะกะžะ›ะžะ“ะ˜ะฏ

    • Year: 2025-03-26

Foraging of Honeybees from Different Ecological Areas Determined through Melissopalynological Analysis and DNA Metabarcoding

    • Authors: Saule Daugaliyeva, Aida Daugaliyeva, Katira Amirova, Akmeiir Yelubayeva, Abylay Kapar, Aishat Abiti, Thomas Partipilo, Nurlan Toktarov, Simone Peletto

    • Journal: Insects

    • Year: 2024-09-05

Molecular typing methods to characterize Brucella spp. from animals: A review

    • Authors: Aida Daugaliyeva, Saule Daugaliyeva, Nazerke Kydyr, Simone Peletto

    • Journal: Veterinary World

    • Year: 2024-08

Foraging of Honeybees from Different Ecological Areas Determined through Melissopalynological Analysis and DNA Metabarcoding

    • Authors: Saule Daugaliyeva, Aida Daugaliyeva, Katira Amirova, Akmeiir Yelubayeva, Abylay Kapar, Aishat Abiti, Thomas Partipilo, Nurlan Toktarov, Simone Peletto

    • Journal: Preprint

    • Year: 2024-07-30

 

Jianfei Sun | Biosensing and Bioimaging | Best Researcher Award

Posted on by ScienceFather

Prof. Jianfei Sun | Biosensing and Bioimaging | Best Researcher Award

Southeast University | China

Publication Profile:

Google Scholar

๐Ÿ‘จโ€๐ŸŽ“ Summary:

Prof. Jianfei Sun is a distinguished researcher and doctoral supervisor at Southeast University, China. He specializes in magnetic nanomaterials for medicine and electromagnetic therapy. As the director of the Jiangsu Key Laboratory of Biomaterials and Devices, he has pioneered methods for overcoming depth limitations in medical treatments using magnetic stimulation. With over 90 academic papers and 9 invention patents, Prof. Sun’s work has contributed significantly to both scientific advancements and technology transfer.

๐ŸŽ“ Education:

Prof. Sun holds a doctoral degree in a relevant field and has completed extensive research in biomaterials and electromagnetic therapies.

๐Ÿ’ผ Professional Experience:

Prof. Sun has a notable academic career at Southeast University, where he supervises doctoral students and leads cutting-edge research in biomedical engineering. His work focuses on developing advanced magnetic nanomaterials for medical applications and their integration into clinical therapies.

๐Ÿ“š Academic Citations:

Prof. Sun has authored over 90 papers published in renowned academic journals, including key publications in Zoological Research, ACS Applied Materials & Interfaces, and Applied Physics A. His research has been widely cited, making a significant impact in the field of medical magnetism.

๐Ÿ› ๏ธ Technical Skills:

  • Magnetic Nanomaterial Synthesis

  • Electromagnetic Therapy Development

  • Precision Magnetic Stimulation

  • Biomaterial Application in Medicine

  • Patented Technology in Nanotechnology

๐Ÿ‘จโ€๐Ÿซ Teaching Experience:

Prof. Sun has contributed to academia as a doctoral supervisor at Southeast University, mentoring students in the fields of biomaterials, nanotechnology, and medical engineering.

๐Ÿ”ฌ Research Interests:

His research is centered on the application of magnetic nanomaterials in medicine, particularly in electromagnetic therapies for neurological diseases. Prof. Sunโ€™s pioneering work includes precision magnetic stimulation methods and nano-iron oxide materials used for therapeutic purposes.

๐Ÿ“šย Top Notes Publications:

Co-seismic ruptures of the 12 May 2008, Ms 8.0 Wenchuan earthquake, Sichuan: Eastโ€“west crustal shortening on oblique, parallel thrusts along the eastern edge of Tibet

    • Authors: J Liu-Zeng, Z Zhang, L Wen, P Tapponnier, J Sun, X Xing, G Hu, Q Xu, …

    • Journal: Earth and Planetary Science Letters

    • Year: 2009

Response of MAPK pathway to iron oxide nanoparticles in vitro treatment promotes osteogenic differentiation of hBMSCs

    • Authors: Q Wang, B Chen, M Cao, J Sun, H Wu, P Zhao, J Xing, Y Yang, X Zhang, …

    • Journal: Biomaterials

    • Year: 2016

Magnetic field and nano-scaffolds with stem cells to enhance bone regeneration

    • Authors: Y Xia, J Sun, L Zhao, F Zhang, XJ Liang, Y Guo, MD Weir, MA Reynolds, …

    • Journal: Biomaterials

    • Year: 2018

A novel magnetic hydrogel with aligned magnetic colloidal assemblies showing controllable enhancement of magnetothermal effect in the presence of alternating magnetic field

    • Authors: K Hu, J Sun, Z Guo, P Wang, Q Chen, M Ma, N Gu

    • Journal: Advanced Materials

    • Year: 2015

Effect of drip irrigation on strawberry growth and yield inside a plastic greenhouse

    • Authors: BZ Yuan, J Sun, S Nishiyama

    • Journal: Biosystems Engineering

    • Year: 2004

Tacrineโ€“ferulic acidโ€“nitric oxide (NO) donor trihybrids as potent, multifunctional acetyl-and butyrylcholinesterase inhibitors

    • Authors: Y Chen, J Sun, L Fang, M Liu, S Peng, H Liao, J Lehmann, Y Zhang

    • Journal: Journal of Medicinal Chemistry

    • Year: 2012

Elลผbieta Zล‚owocka-Perล‚owska | kidney cancer | Best Researcher Award

Posted on by ScienceFather

Dr. Elลผbieta Zล‚owocka-Perล‚owska | kidney cancer | Best Researcher Award

Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University | Poland

PUBLICATION PROFILE

Orcid

Dr. Elลผbieta Zล‚owocka-Perล‚owskaโšก๐ŸŒ

INTRODUCTION ๐ŸŒŸ

Dr. Elลผbieta Zล‚owocka-Perล‚owska is a distinguished academic and researcher at the Pomeranian Medical University, specializing in clinical genetics, molecular biology, and hereditary cancers. With over two decades of dedication to the Hereditary Cancer Center at the Department of Genetics and Pathomorphology, she has become an influential figure in medical sciences, particularly focusing on bladder and kidney cancer research. Her work aims to integrate trace element analysis into personalized cancer treatment models, contributing significantly to the field of molecular genetics.

EARLY ACADEMIC PURSUITS ๐ŸŽ“

Dr. Zล‚owocka-Perล‚owska’s academic journey began with a diploma in Biology from the University of Szczecin in 2002. She then pursued a PhD in Medical Sciences at Pomeranian Medical Academy in Szczecin, where she earned her degree with distinction in 2008. Throughout her early academic years, she demonstrated a deep commitment to the study of genetics and its implications for cancer research.

PROFESSIONAL ENDEAVORS ๐Ÿ’ผ

Since 2002, Dr. Zล‚owocka-Perล‚owska has been associated with the Hereditary Cancer Center at the Pomeranian Medical University. Her career has evolved from a PhD student to a University Lecturer, Assistant Professor, and National Consultant in Clinical Genetics. She has taught both Polish and English-language courses across various medical and biotechnology programs. Dr. Zล‚owocka-Perล‚owska’s professional endeavors have led her to direct research projects on cancer diagnostics, utilizing molecular techniques like MLPA, TaqMan, and NGS.

CONTRIBUTIONS AND RESEARCH FOCUS ON kidney cancer๐Ÿ”ฌ

Dr. Zล‚owocka-Perล‚owskaโ€™s research is centered on the study of hereditary cancers, particularly bladder and kidney cancers. Her current research project aims to explore the role of trace elements in cancer prognosis, with a specific focus on blood and serum selenium levels as potential markers for survival. She has conducted extensive studies using molecular genetics techniques and has made significant contributions to the understanding of hereditary cancer genetics. Her scientific work has culminated in 51 publications, four patents (including an international patent), and numerous conference presentations.

IMPACT AND INFLUENCE ๐ŸŒ

As a recognized leader in the field of hereditary cancer research, Dr. Zล‚owocka-Perล‚owska has had a profound impact on both medical education and healthcare. Her contributions to clinical studies, research, and the advancement of cancer treatments have been recognized internationally. Through her scientific publications and involvement in research projects, she continues to influence the development of personalized medicine and clinical genetics.

ACADEMIC CITATIONS AND PUBLICATIONS ๐Ÿ“š

Dr. Zล‚owocka-Perล‚owska is the author and co-author of numerous scientific papers published in national and international journals. Her work focuses on hereditary cancers and molecular biology, contributing to the advancement of clinical genetics. With 51 publications to her name, her research is frequently cited by peers in the scientific community. Her papers have been presented at several renowned scientific conferences, establishing her as a thought leader in her field.

HONORS & AWARDS ๐Ÿ†

Dr. Zล‚owocka-Perล‚owska has received numerous accolades throughout her career, including the Minister of Healthโ€™s Team Award in 2005 and the prestigious “Eminent Scientist of the Year 2009” award from the World Scientist Forum International Awards. She has also been honored with multiple Rectorโ€™s Awards for her scientific achievements at Pomeranian Medical University. Other recognitions include certifications for NGS sequencing training and contributions to laboratory medical genetics.

FINAL NOTE โœจ

Dr. Zล‚owocka-Perล‚owskaโ€™s work is a testament to the power of academic dedication and scientific inquiry. Her commitment to advancing medical genetics, particularly in the study of hereditary cancers, has significantly shaped the field. Through her research, teaching, and clinical contributions, she continues to inspire future generations of scientists and clinicians.

LEGACY AND FUTURE CONTRIBUTIONS ๐Ÿ”ฎ

Dr. Zล‚owocka-Perล‚owskaโ€™s ongoing research on cancer treatment and prognostic markers positions her as a key figure in the evolution of personalized medicine. With her focus on integrating molecular techniques and trace element analysis, her future contributions will likely continue to revolutionize cancer diagnostics and treatment. She leaves a lasting legacy in the field of medical genetics, with a promising trajectory for further scientific discovery.

TOP NOTES PUBLICATIONSย ๐Ÿ“š

1. Blood and Serum Copper and Zinc Levels and 10-Year Survival of Patients After Kidney Cancer Diagnosis

  • Authors: Elลผbieta Zล‚owocka-Perล‚owska, Piotr Baszuk, Wojciech Marciniak, Rรณลผa Derkacz, Aleksandra Toล‚oczko-Grabarek, Katarzyna Goล‚ฤ™biewska, Marcin Sล‚ojewski, Adam Goล‚ฤ…b, Artur Lemiล„ski, Michaล‚ Soczawa, et al.
  • Journal: Nutrients
  • Year: 2025
  • DOI: 10.3390/nu17060944

2. Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland

  • Authors: Elลผbieta Zล‚owocka-Perล‚owska, Aleksandra Toล‚oczko-Grabarek, Steven A. Narod, Jan Lubiล„ski
  • Journal: Hereditary Cancer in Clinical Practice
  • Year: 2022
  • DOI: 10.1186/s13053-022-00220-6

3. Germline HOXB13 mutation p.G84E do not confer an increased bladder or kidney cancer risk in Polish population

  • Authors: Elลผbieta Zล‚owocka-Perล‚owska, Aleksandra Toล‚oczko-Grabarek, Jan Lubiล„ski
  • Journal: Hereditary Cancer in Clinical Practice
  • Year: 2022
  • DOI: 10.1186/s13053-021-00208-8

4. Recurrent PALB2 mutations and the risk of cancers of bladder or kidney in Polish population

  • Authors: Elลผbieta Zล‚owocka-Perล‚owska, Aleksandra Toล‚oczko-Grabarek, Jan Lubiล„ski
  • Journal: Hereditary Cancer in Clinical Practice
  • Year: 2021
  • DOI: 10.1186/s13053-020-00161-y

5. Survival of bladder or renal cancer in patients with CHEK2 mutations

  • Authors: Elลผbieta Zล‚owocka-Perล‚owska, Alvaro Galli, Tadeusz Dฤ™bniak, Marcin Sล‚ojewski, Thierry van de Wetering, Aleksandra Toล‚oczko-Grabarek, Cezary Cybulski, Rodney J. Scott, Jan Lubiล„ski
  • Journal: PLOS ONE
  • Year: 2021
  • DOI: 10.1371/journal.pone.0257132

 

Qurban Ali | Genetics | Best Researcher Award

Posted on by ScienceFather

Assist Prof Dr. Qurban Ali | Genetics | Best Researcher Award

University of the Punjab, Lahore | Pakistan

Publication Profile

Google Scholar
Scopus
Orcid

INTRODUCTION ๐Ÿ“š

Dr. Qurban Ali, an esteemed academic in the field of Plant Genetics, currently serves as an Assistant Professor in the Department of Plant Breeding and Genetics at the University of the Punjab, Lahore. His contributions span over two decades, with a remarkable academic and professional trajectory. Dr. Ali has demonstrated his commitment to advancing research in agricultural sciences, particularly in genetics, molecular biology, and biotechnology. His work is widely recognized for its impact on both local and global agricultural development.

EARLY ACADEMIC PURSUITS ๐ŸŽ“

Dr. Qurban Ali’s academic journey began in Pakistan, where he completed his early schooling in science at the Board of Intermediate & Secondary Education, Lahore. After pursuing a Pre-Medical stream in HSSC, he continued his education at the University of Agriculture, Faisalabad, where he earned a B.Sc. (Hons.) and M.Sc. (Hons.) in Plant Genetics. His doctoral research, completed in 2014, focused on the genetic evaluation of maize accessions for grain and fodder yield, paving the way for his future academic contributions.

PROFESSIONAL ENDEAVORS ๐Ÿ’ผ

Dr. Ali has held several prestigious positions at renowned institutes and universities, including Assistant Professor at the University of the Punjab and Associate Professor at the University of Lahore. With a comprehensive background in molecular biology and biotechnology, he has significantly advanced research in these fields through his roles in academic and research organizations.

CONTRIBUTIONS AND RESEARCH FOCUSย  ON Genetics ๐Ÿ”ฌ

His primary research areas include plant genetics, molecular breeding, and biotechnology, with notable expertise in DNA/RNA extraction, cloning, gene transformation, protein purification, and more. Dr. Aliโ€™s work has provided substantial advancements in understanding the genetic variability and association of traits in crops like maize and chickpea, contributing to improved agricultural practices.

IMPACT AND INFLUENCE ๐ŸŒ

Dr. Aliโ€™s research has had a lasting influence on both academia and the agricultural industry. His work has contributed to the scientific communityโ€™s understanding of plant genetics and the application of advanced molecular techniques to solve agricultural challenges. As a highly cited researcher, he has been recognized for his contributions to improving crop yield and genetic enhancement.

ACADEMIC CITATIONS AND PUBLICATIONS ๐Ÿ“

With a cumulative impact factor of 350, Dr. Aliโ€™s academic output includes numerous publications, making him a prominent figure in plant breeding and genetics. His citation indices reflect his extensive influence in the scientific community, with 6,753 total citations and an h-index of 43. Dr. Aliโ€™s scholarly work continues to shape the field and inspire future research.

HONORS & AWARDS ๐Ÿ…

Dr. Ali has been honored with prestigious awards for his outstanding research productivity. These accolades include the โ€œResearch Productivity as Eminent Researcher of the Yearโ€ award for five consecutive years (2019-2023) from the University of Lahore and the University of the Punjab, Lahore. Such recognition underscores his dedication to advancing agricultural science.

LEGACY AND FUTURE CONTRIBUTIONS ๐Ÿ”ฎ

Dr. Aliโ€™s legacy as an academic and researcher is solidified through his numerous publications, contributions to the development of plant genetics, and mentorship of students and researchers. Looking forward, he aims to continue advancing his research in molecular biology and genetics, with an emphasis on sustainable agricultural practices and crop improvement.

FINAL NOTE โœจ

Dr. Qurban Ali stands as a trailblazer in the field of Plant Genetics, whose research has not only contributed to scientific understanding but has also led to practical solutions for agricultural improvement. His unwavering commitment to excellence continues to guide the next generation of researchers in the field.

TOP NOTES PUBLICATIONS ๐Ÿ“š

Advances in CRISPR/Cas9 technology: shaping the future of photosynthetic microorganisms for biofuel production
  • Authors: Samreen Arshad, Muhammad Luqman Qadir, Nazim Hussain, Qurban Ali, Shiming Han, Daoud Ali, Suleyman Allakhverdiev
    Journal: Functional Plant Biology
    Year: 2025
    DOI: 10.1071/FP24255
Antibacterial potential of Propolis: molecular docking, simulation and toxicity analysis
  • Authors: Shabana Islam, Erum Akbar Hussain, Shahida Shujaat, Muhammad Umer Khan, Dr. Qurban Ali, Saif Ul Malook, Daoud Ali
    Year: 2024
    DOI: 10.6084/m9.figshare.26315515
ย Silibinins and curcumin as promising ligands against mutant cystic fibrosis transmembrane regulator protein
  • Authors: Areeba Akram, Azra Sakhawat, Muhammad Usman Ghani, Muhammad Umer Khan, Raima Rehman, Dr. Qurban Ali, Peng Jin-liang, Daoud Ali
    Year: 2024
    DOI: 10.6084/m9.figshare.26752912
Additional file 2 of Antibacterial potential of Propolis: molecular docking, simulation and toxicity analysis
  • Authors: Shabana Islam, Erum Akbar Hussain, Shahida Shujaat, Muhammad Umer Khan, Dr. Qurban Ali, Saif Ul Malook, Daoud Ali
  • Journal: figshare (DataCite)
  • Year: 2024
  • DOI: 10.6084/m9.figshare.26315699.v1
Genome-wide identification of Cytochrome P450 gene in Fall Armyworm (Spodoptera frugiperda) in response to insecticide resistance
  • Authors: Shabana Islam, Erum Akbar Hussain, Shahida Shujaat, Muhammad Umer Khan, Dr. Qurban Ali, Saif Ul Malook, Daoud Ali
  • Journal: figshare (DataCite)
  • Year: 2024
  • DOI: 10.6084/m9.figshare.26315699.v1

 

Susanne Staehlke | Cell-Biomaterial-Interaction | Best Researcher Award

Posted on by ScienceFather

Dr. Susanne Staehlke | Cell-Biomaterial-Interaction | Best Researcher Award

Rostock University Medical Center | Germany

Author Profile

Orcidย 

๐Ÿ“š EARLY ACADEMIC PURSUITS

Dr. Susanne Staehlke began her academic journey with a focus on Genetic and Microbiology at the University of Rostock, Germany, from 2000 to 2006. During this time, she specialized in signal transduction in Oncorhynchus mykiss (rainbow trout), which laid the foundation for her interest in molecular biology and cell signaling. She continued her studies at Rostock University Medical Center, where she earned her PhD in Cell Biology in 2014. Her doctoral research focused on the interaction between human osteoblasts and geometrically structured implant surfaces, specifically investigating cell architecture and signal transduction.

๐Ÿ’ผ PROFESSIONAL ENDEAVORS

Dr. Staehlkeโ€™s career as a scientist includes an extensive background in cell biology, biomaterials, and tissue engineering. After earning her PhD, she embarked on post-doctoral research that expanded her expertise into ophthalmology, where she focused on understanding cell responses to surface modifications for ocular applications. Her work in this area also involved collaborations with experts in various fields, including engineering, physics, chemistry, and medicine, to enhance biomaterial designs for clinical applications. Throughout her career, Dr. Staehlke has contributed to over 40 publications, and her work has made significant strides in the fields of biomaterials and regenerative medicine.

๐Ÿ”ฌ CONTRIBUTIONS AND RESEARCH FOCUS ON Cell-Biomaterial-Interaction

Dr. Staehlke has made a profound impact in the fields of biomaterials, cell biology, and tissue engineering. Her primary research focus has been on optimizing cell-biomaterial interactions, particularly improving osteoblast responses to implant surfaces. By investigating physico-chemical surface modifications, such as plasma polymer coatings and topographical features, Dr. Staehlkeโ€™s work has advanced biomaterial design, enhancing cell behavior and implant integration. Additionally, her research in the integration of artificial intelligence (AI), machine learning, and big data analytics has enabled better prediction of cellular responses to various biomaterials. Her interdisciplinary approach has driven significant advancements in regenerative medicine, stem cell characterization, and biomedicines.

๐ŸŒ IMPACT AND INFLUENCE

Dr. Staehlkeโ€™s contributions to science have had a lasting influence on biomaterial innovation, tissue engineering, and regenerative medicine. Her work has led to groundbreaking advances in surface modifications for implants, improving both the functional and biological success of biomaterials. Dr. Staehlke has also been instrumental in enhancing the reproducibility of scientific research by advocating for rigorous data analysis methods and the development of open-source platforms for data management. Her interdisciplinary approach, which bridges cell biology with computational tools and engineering, has strengthened scientific rigor and fostered collaborations across diverse fields.

๐Ÿ“‘ ACADEMIC CITES

Dr. Staehlkeโ€™s work has garnered significant academic recognition, with over 40 publications in leading journals within the fields of biomaterials, cell biology, and tissue engineering. Her research is widely cited, contributing to the advancement of knowledge in cell-biomaterial interactions. She has a citation index of 506 and an h-index of 12, demonstrating the profound impact and influence of her scholarly contributions.

๐Ÿ›๏ธ LEGACY AND FUTURE CONTRIBUTIONS

Dr. Staehlkeโ€™s legacy in the scientific community will likely continue to grow as her research paves the way for new biomaterial technologies and therapeutic applications in regenerative medicine. Her integration of AI and big data into cell biology and biomaterials research ensures that her future contributions will further refine predictive models for cellular behavior, ultimately improving patient outcomes in tissue engineering and implantology. As she continues to collaborate with experts from various disciplines, Dr. Staehlkeโ€™s work promises to influence both academic research and clinical practice for years to come.

๐Ÿค KEY COLLABORATIONS

Throughout her career, Dr. Staehlke has worked closely with interdisciplinary teams, including engineers, clinicians, data scientists, and materials scientists. Her research has benefited from collaborations in the fields of ophthalmology, biomaterials, and systems biology. These partnerships have led to innovative approaches for improving cell-biomaterial interactions and advancing technologies in regenerative medicine. Additionally, her work with AI and machine learning specialists has allowed her to optimize experimental data analysis, which has been essential for ensuring reproducibility and improving the predictive accuracy of her research findings.

๐Ÿง‘โ€๐Ÿ”ฌ PROFESSIONAL MEMBERSHIPS

Dr. Staehlke holds memberships in several professional organizations, including the German Society for Biomaterials (DGBM), TERMIS (Tissue Engineering and Regenerative Medicine International Society), and the German Ophthalmology Society (DOG). These memberships reflect her commitment to staying at the forefront of developments in her field and engaging with a global network of researchers and professionals.

๐Ÿ“Š RESEARCH DATA ANALYSIS AWARDS

Dr. Staehlkeโ€™s research has also been recognized in the field of data analysis, particularly for her innovative approaches in handling complex datasets related to cell-biomaterial interactions. This dedication to data integrity and reproducibility has earned her numerous accolades and collaborations with experts in scientific workflows and AI-powered data analysis tools.

๐Ÿ“‘ NOTABLE PUBLICATIONSย 

Impact of Metal Ions on Cellular Functions: A Focus on Mesenchymal Stem/Stromal Cell Differentiation
    • Authors: Kirsten Peters, Susanne Staehlke, Henrike Rebl, Anika Jonitz-Heincke, Olga Hahn
    • Journal: International Journal of Molecular Sciences
    • Year: 2024
Suppressing Pro-Apoptotic Proteins by siRNA in Corneal Endothelial Cells Protects against Cell Death
    • Authors: Susanne Staehlke, Siddharth Mahajan, Daniel Thieme, Peter Trosan, Thomas A. Fuchsluger
    • Journal: Biomedicines
    • Year: 2024
Cold Atmospheric Pressure Plasma-Activated Medium Modulates Cellular Functions of Human Mesenchymal Stem/Stromal Cells In Vitro
    • Authors: Olga Hahn, Tawakalitu Okikiola Waheed, Kaarthik Sridharan, Thomas Huemerlehner, Susanne Staehlke, Mario Thรผrling, Lars Boeckmann, Mareike Meister, Kai Masur, Kirsten Peters
    • Journal: International Journal of Molecular Sciences
    • Year: 2024
The Impact of Ultrashort Pulse Laser Structuring of Metals on In-Vitro Cell Adhesion of Keratinocytes
    • Authors: Susanne Staehlke, Tobias Barth, Matthias Muench, Joerg Schroeter, Robert Wendlandt, Paul Oldorf, Rigo Peters, Barbara Nebe, Arndt-Peter Schulz
    • Journal: Journal of Functional Biomaterials
    • Year: 2024
Short-Time Alternating Current Electrical Stimulation and Cell Membrane-Related Components
    • Authors: Maren E. Buenning, Meike Bielfeldt, Barbara Nebe, Susanne Staehlke
    • Journal: Applied Sciences
    • Year: 2024

Ana Lรบcia Pereira | Tecnologia de alimentos | Best Researcher Award

Posted on by ScienceFather

Prof Dr. Ana Lรบcia Pereira | Tecnologia de alimentos | Best Researcher Award

Federal University Of Maranhรฃo, Brazil

Author Profiles

Orcid

Scopus

Early Academic Pursuits ๐ŸŽ“

Dr. Ana Lรบcia Fernandes Pereira’s academic journey began with a solid foundation in food engineering, where she developed a deep interest in food science and technology. She pursued higher education at renowned institutions, eventually becoming an associate professor at the Federal University of Maranhรฃo (UFMA). Her academic career has been marked by continuous learning and professional development, making significant strides in both teaching and research.

Professional Endeavors ๐Ÿ’ผ

Dr. Pereira is an associate professor II and a researcher at UFMA, specializing in the undergraduate course in Food Engineering. She also teaches and advises in the Postgraduate Program in Health and Technology. Additionally, she coordinates the Food Science and Technology research group, contributing substantially to both academia and the food science industry. Throughout her career, she has published 70 scientific articles and 9 book chapters, along with 287 conference papers, showcasing her active role in advancing the field.

Contributions and Research Focus ๐Ÿ”ฌ

Dr. Pereiraโ€™s research primarily focuses on technological innovations in food science. Her completed and ongoing projects highlight her dedication to developing functional and sustainable food products. Notable works include the creation of a probiotic drink from exotic fruits, and the preservation of eggs using coatings from babassu oil and starch. Her current projects continue to build on this legacy, such as the development of kombucha from hibiscus leaves and sweet biscuits made with babassu mesocarp flour.

Impact and Influence ๐ŸŒ

Dr. Pereiraโ€™s work has had a profound impact on the field of food science and technology, particularly in the Brazilian context. Her research on regional and tropical fruits, functional foods, and sustainable food packaging is pushing the boundaries of innovation in the food industry. Through collaborations in national networks and with various universities and research institutions, she has influenced both academic circles and industries related to food engineering and health.

Academic Cites ๐Ÿ“š

With a citation index of 13, Dr. Pereiraโ€™s contributions to scientific literature have been widely recognized by her peers. Her work, particularly in the development of functional foods and sustainable technologies, continues to inspire future research and innovation in food science. Her academic influence is reflected in the high number of articles, book chapters, and conference proceedings she has authored or co-authored.

Technical Skills ๐Ÿ”ง

Dr. Pereira is highly skilled in a range of technical areas related to food engineering, food preservation, and functional food development. Her expertise extends to the use of local ingredients such as babassu and aรงaรญ, as well as advanced methods for creating probiotics, edible coatings, and kombucha. Her ability to bridge the gap between research and practical applications has made her a key figure in the advancement of food technology.

Teaching Experience ๐ŸŽ

Dr. Pereira has a rich teaching history, having educated and mentored students at both undergraduate and postgraduate levels. As a professor in the Food Engineering program and the Postgraduate Program in Health and Technology, she has played a vital role in shaping the next generation of food scientists. Her guidance in research and innovation has helped many students pursue successful careers in food technology and related fields.

Legacy and Future Contributions ๐ŸŒฑ

Dr. Pereira’s legacy is one of innovation and commitment to improving food science. Her research has already had significant contributions to functional foods and sustainable food technologies. Moving forward, her focus on tropical and regional fruits, as well as the health benefits of food, will likely continue to influence both academic research and industry practices. Her involvement in national and international projects promises to leave a lasting impact on the global food science community.

Consultancy and Industry Projects ๐Ÿ’ก

Dr. Pereira is also involved in the startup world through her consultancy work with Vinnori, where she develops edible coatings based on plants from the semiarid region. This collaboration showcases her ability to translate scientific research into viable commercial solutions, thus contributing to the development of more sustainable food production systems.

 

Top Noted Publications๐Ÿ“–

Innovative blends with probiotic potential: Processing optimization, bioactive compounds, and sensory evaluation of yellow mombin (Spondias mombin) and Talinum triangulare beverages

Authors: Alves, D.M.D.M., Soeiro, A.L., Leite, W.S.M., Lemos, T.D.O., Pereira, A.L.F.
Journal: International Journal of Gastronomy and Food Science
Year: 2024

ย Immunomodulatory Activity of Probiotics in Models of Bacterial Infections

Authors: Dias, T.G., Rodrigues, L.D.S., Farias, J.R., Monteiro-Neto, V., Maciel, M.C.G.
Journal: Probiotics and Antimicrobial Proteins
Year: 2024

Antioxidant and Antimicrobial Properties of Probiotics: Insights from In Vitro Assays

Authors: Costa, F.F., Dias, T.G., Mendes, P.M., Reis, A.S., Maciel, M.C.G.
Journal: Probiotics and Antimicrobial Proteins
Year: 2024

Enhancing star fruit shelf life using edible coatings from babassu starch and oil with plasticizers (Portuguese title: Aumento da estabilidade de carambolas com uso de coberturas de amido e รณleo de babaรงu com plastificantes)

Authors: Pinto, R.A., da Silva, R.A., Mendonรงa, G.R., Ferreira, D.S., Pereira, A.L.F.
Journal: Pesquisa Agropecuaria Brasileira
Year: 2024

Effectiveness of babassu starch and oil coating with plasticizers to improve shelf life of eggs

Authors: Mendonรงa, G.R., Campos, R.S., da Silva, R.A., Freitas, E.R., Pereira, A.L.F.
Journal: Journal of Coatings Technology and Research
Year: 2024

Nabras Al-Mahrami | Proteomics | Best Researcher Award

Posted on by ScienceFather

Mr. Nabras Al-Mahrami | Proteomics | Best Researcher Award

Oman College of Health Sciences, Oman

Author Profiles ๐Ÿ“š

Scopus

Orcid

Early Academic Pursuits ๐ŸŽ“

Mr. Nabras Al-Mahramiโ€™s academic journey has been marked by a strong foundation in molecular medicine and bioinformatics. After completing his BSc in Medical Laboratory Science at Oman College of Health Sciences in 2018, he pursued an MSc in Molecular Medicine (Bioinformatics) at the Cyprus Institute of Neurology and Genetics in Cyprus, graduating in 2022. His research project, titled “Bioinformatics approach to related genetic variants with functionality, phenotype, and pathogenicity,” underscores his deep interest in understanding the genetic basis of diseases through bioinformatics techniques. This academic background enabled him to merge laboratory science with computational biology seamlessly.

Professional Endeavors ๐Ÿงฌ

Mr. Al-Mahrami has developed a strong professional profile, especially in bioinformatics, through his roles at Oman College of Health Sciences and the National Genetic Center. As a Bioinformatician at the Royal Hospital in Muscat from 2018 to 2024, he played a key role in genomics data analysis, developing pipelines for whole genome sequencing (WGS), whole exome sequencing (WES), and target panel analysis. His work also spanned Genome-Wide Association Studies (GWAS), Gene Set Enrichment Analysis (GSEA), RNA-seq analysis, and proteomics data analysis, demonstrating his broad and diverse expertise in the molecular biology and bioinformatics fields.

Contributions and Research Focus ๐Ÿ”ฌ

Mr. Al-Mahramiโ€™s research has greatly contributed to the field of bioinformatics, particularly in genetic variant analysis, phenotypic predictions, and understanding the pathogenicity of diseases. His use of advanced tools like machine learning, molecular docking, and network interaction analysis in the development of bioinformatics tools has further enhanced the precision of genomic research. His impactful research involves bridging the gap between bioinformatics, molecular genetics, and clinical applications, fostering advancements in precision medicine.

Impact and Influence ๐ŸŒ

Through his work, Mr. Al-Mahrami has influenced bioinformatics research not only in Oman but globally. His involvement in high-profile conferences, such as the 5th Congress of Reproductive Genetics and the Precision Med Exhibit and Summit 2023, has allowed him to share his insights on cutting-edge genetic technologies and their clinical applications. His academic contributions have positioned him as a key figure in applying bioinformatics approaches to real-world medical challenges.

Academic Cites ๐Ÿ“š

Mr. Al-Mahrami has contributed significantly to academic advancements. His research and presentations have been featured at various scientific conferences and workshops, such as the Gene Set Enrichment Analysis Workshop hosted by the Swiss Bioinformatics Institute. His academic works and insights into genetic technologies are widely cited and discussed in the bioinformatics and medical communities, particularly regarding the potential of AI-driven bioinformatics tools in healthcare.

Technical Skills ๐Ÿ’ป

Mr. Al-Mahrami possesses advanced technical skills essential for modern bioinformatics. His proficiency in R (RStudio) and Python programming allows him to handle large datasets and perform complex analyses, while his experience with Linux OS and HPC ensures that his computational work is efficient and scalable. Additionally, his knowledge in CSS and JavaScript aids in the development of user-friendly bioinformatics tools and applications.

Teaching Experience๐Ÿ‘จโ€๐Ÿซ

In 2024, Mr. Al-Mahrami took on the role of Academic Faculty in Bioinformatics at Oman College of Health Sciences, where he teaches Principles of Bioinformatics, covering both theoretical and practical modules, and Laboratory Management. His ability to impart knowledge to students helps shape the next generation of bioinformaticians, ensuring they are equipped with both theoretical insights and hands-on experience in the field. His passion for education extends beyond the classroom, influencing students to pursue careers in bioinformatics and molecular medicine.

Legacy and Future Contributions ๐ŸŒŸ

Looking forward, Mr. Al-Mahramiโ€™s journey is marked by his commitment to expanding bioinformatics research and education in Oman and beyond. His work in genomic data analysis, AI integration, and bioinformatics tools development lays the groundwork for future innovations in personalized medicine. His legacy will likely include contributing to groundbreaking research and training future generations of bioinformaticians, particularly in regions with emerging biomedical research landscapes. With his continued involvement in both academia and research, his influence on the scientific community is poised to grow, fostering a deeper understanding of the genetic basis of diseases and improving patient care globally.

Top Noted Publications ๐Ÿ“–

Exploring advanced genomic and immunoinformatics techniques for identifying drug and vaccine targets against SARS-CoV-2
    • Authors: Syed Luqman Ali, Awais Ali, Waseef Ullah, Abdulaziz Alamri, Elham Mohammed Khatrawi, Gulzira Sagimova, Aigul Almabayeva, Farida Rakhimzhanova, Gulsum Askarova, Fatima Suleimenova et al.
    • Journal: Journal of Genetic Engineering and Biotechnology
    • Year: 2024
In-silico and in-vitro studies to identify potential inhibitors of SARS-CoV-2 spike protein from Omani medicinal plants
    • Authors: Nabras Al-Mahrami, Smitha Sunil Kumaran Nair, Adhra Al Mawali, Raja-Mohamed Beema Shafreen, Saeed Ullah, Sobia Ahsan Halim, Ahmed Al-Harrasi, Nallusamy Sivakumar
    • Journal: Heliyon
    • Year: 2024
Bioinformatics Approach is Unraveling Potential Crosstalk between Cytomegalovirus and Epilepsy
    • Authors: Salim Al Rashdi, Nabras Al-Mahrami
    • Journal: Preprint
    • Year: 2024
PlantMedOman: an online database for Oman’s medicinal plants
    • Authors: Department of Computing and Electronics Engineering, Middle East College, Sultanate of Oman; Smitha Sunil Kumaran Nair; Aqsa Bibi; Nabras Al-Mahrami; Piyusha Mahesh Satam; Alya Al Farsi et al.
    • Journal: Bioinformation
    • Year: 2024

Neda Fayyazi | Bioinformatics | Excellence in Innovation

Posted on by ScienceFather

Dr. Neda Fayyazi | Bioinformatics | Excellence in Innovation

ogen/ medical iincubator, Iran

ย Author Profile ๐Ÿ“š

Google Scholar

Early Academic Pursuits ๐ŸŽ“

Dr. Neda Fayyazi’s academic journey is marked by significant achievements, beginning with her Ph.D. in Pharmaceutical and Medicinal Chemistry from Isfahan University of Medical Sciences, which she completed between February 2015 and October 2019. Her outstanding academic performance earned her a top rank (A) with a GPA of 3.60. Dr. Fayyazi’s thesis, titled Molecular modeling, synthesis, and biological evaluation of hybrid multi-target iron chelators for anticancer and antimalarial applications, was highly regarded, securing an Excellent Rank (A). Her interdisciplinary focus on combining computational techniques and medicinal chemistry positions her as an emerging leader in the field.

Professional Endeavors ๐Ÿ’ผ

Dr. Fayyazi’s professional experience spans academia and industry, with roles in pharmaceutical companies and research institutions. She has worked with leading organizations, including TPCO Holding, Pars Darou Pharmaceutical Company, and Barkat Holding. Her roles involved product development, technology transfer, and research in the areas of pharmaceutical formulations, softgel production, and drug discovery. As a board member of Ozhan Pharma Group and an active participant in various projects, Dr. Fayyazi continues to bridge the gap between scientific research and commercial application.

Contributions and Research Focus ๐Ÿ”ฌ

Dr. Fayyaziโ€™s research contributions are primarily in the field of Medicinal Chemistry, with a focus on drug design, molecular modeling, and hybrid molecule synthesis. Her work on molecular dynamics simulations and protein-ligand interactions using cutting-edge tools like Gromacs, GOLD, and Discovery Studio has been instrumental in advancing the understanding of drug interactions at the molecular level. Additionally, she is passionate about developing novel drug delivery systems, particularly in sustained-release formulations, and exploring natural products for therapeutic potential. Her research integrates AI and machine learning approaches in drug discovery, a testament to her forward-thinking methodology.

Impact and Influence ๐ŸŒ

Dr. Fayyazi has had a significant impact on the pharmaceutical industry and academia through her work in drug discovery, technology transfer, and industry collaboration. Her expertise in bioassay-guided screening and cancer therapy research has led to breakthroughs in medicinal chemistry, especially in the development of multi-target anticancer agents. As a member of various prestigious associations such as the European Bioinformatics Association and the American Chemical Society, she has contributed to the global advancement of biotechnology and pharmaceutical sciences. Her work has garnered recognition, including a prize for innovative ideas in drug research at the Euro Chemistry Conference in Berlin (2019).

Academic Cites and Research Recognition ๐Ÿ“‘

Dr. Fayyazi’s academic publications and research outputs are highly cited in the fields of molecular modeling and pharmaceutical sciences. Her collaborations with research institutions and pharmaceutical companies have cemented her reputation as a thought leader in medicinal chemistry. Notably, her research on iron chelators and cancer treatment has positioned her as a pivotal figure in advancing drug discovery methodologies. Her work is frequently referenced in studies related to drug design, molecular dynamics, and natural product research.

Technical Skills and Expertise ๐Ÿง‘โ€๐Ÿ”ฌ

Dr. Fayyaziโ€™s technical proficiency extends across a broad spectrum of advanced scientific methods and tools. She is highly skilled in QSAR (Quantitative Structure-Activity Relationship), molecular dynamics simulations, and protein-ligand interactions. Her ability to synthesize hybrid compounds, coupled with her expertise in computational chemistry and machine learning, allows her to investigate complex biochemical interactions and design novel therapeutic agents. Furthermore, her knowledge of Linux environments, scripting, and drug discovery processes in natural products underscores her broad technical competence.

Teaching Experience ๐Ÿ“š

Dr. Fayyaziโ€™s passion for teaching is evident in her role as an educator at Isfahan University of Medical Sciences, where she has taught undergraduate students in organic chemistry, pharmacology, and computational chemistry. She has also supervised and mentored numerous masterโ€™s and Ph.D. students in the fields of medicinal chemistry and bioassays. Her teaching methods emphasize interdisciplinary approaches, integrating cutting-edge technology and scientific research into practical applications.

Legacy and Future Contributions ๐ŸŒŸ

Looking ahead, Dr. Fayyazi’s future contributions are poised to continue shaping the pharmaceutical and biotechnology sectors. Her ongoing projects in controlled release formulations, softgel technology transfer, and sustained-release drug delivery systems demonstrate her commitment to improving patient outcomes through innovative therapeutic solutions. As she works to bridge the gap between academic research and industry applications, Dr. Fayyazi aims to inspire the next generation of scientists and continue her impactful work in drug design and natural product research.

Honor and Awards ๐Ÿ†

Dr. Fayyazi’s career has been punctuated with numerous accolades, including the Best Score in the National Entrance Exam for Pharmaceutical Projects in 2001, the Productivity Management Prize at Soha Pharmaceutical Company (2010), and the prestigious PhD Scholarship for Medicinal Chemistry at Isfahan University. These awards reflect her unwavering dedication to excellence and innovation in both academic and industrial settings.

 

Top Noted Publications ๐Ÿ“–

Molecular dynamics simulation and 3D-pharmacophore analysis of new quinoline-based analogues with dual potential against EGFR and VEGFR-2
    • Authors: N. Fayyazi, A. Fassihi, S. Esmaeili, S. Taheri, J.B. Ghasemi, L. Saghaie
    • Journal: International Journal of Biological Macromolecules
    • Year: 2020
Pharmacophore modeling, synthesis, scaffold hopping and biological ฮฒ-Hematin inhibition interaction studies for anti-malaria compounds
    • Authors: N. Fayyazi, S. Esmaeili, S. Taheri, F.F. Ribeiro, M.T. Scotti, L. Scotti, …
    • Journal: Current Topics in Medicinal Chemistry
    • Year: 2019
Molecular dynamics simulation, 3D-pharmacophore and scaffold hopping analysis in the design of multi-target drugs to inhibit potential targets of COVID-19
    • Authors: N. Fayyazi, T. Mostashari-Rad, J.B. Ghasemi, M.M. Ardakani, F. Kobarfard
    • Journal: Journal of Biomolecular Structure and Dynamics
    • Year: 2022
Design, synthesis, in silico studies, and antiproliferative evaluations of novel indolin-2-one derivatives containing 3-hydroxy-4-pyridinone fragment
    • Authors: P. Shirvani, N. Fayyazi, S. Van Belle, Z. Debyser, F. Christ, L. Saghaie, …
    • Journal: Bioorganic & Medicinal Chemistry Letters
    • Year: 2022
Phytochemical analysis and purification of chief components of Ononis spinosa
    • Authors: N. Fayyazi, F. Naghibi, S. Taheri
    • Journal: N/A
    • Year: 2014
A new insight into the mechanism of loading of Granisetron, Naltrexone and Risperidone in poly (ortho ester) and poly (lactic-co-glycolic acid) as the controlled release drug
    • Authors: L. Karami, N. Fayyazi, M. Akbari, A. Molaei-Baghbanan, M. Maaza
    • Journal: Journal of Drug Delivery Science and Technology
    • Year: 2024

Laurence Vaughan | Medical Diagnostics | Best Researcher Award

Posted on by ScienceFather

Dr. Laurence Vaughan | Medical Diagnostics | Best Researcher Award

Dr. Laurence Vaughan at Becton Dickinson and Company, United States

๐Ÿ‘จโ€๐ŸŽ“ Professional Profile

๐ŸŽ“ Early Academic Pursuits

Dr. Laurence Vaughan began his academic journey at the University of Dublin, Trinity College, where he earned a BA (Honors) in Natural Sciences (Genetics) in 1986, followed by a Ph.D. in Molecular Microbiology in 1991. His doctoral research focused on the aroA gene of Aeromonas salmonicida, contributing to foundational knowledge in microbiology and vaccine development.

๐Ÿข Professional Endeavors

Dr. Vaughanโ€™s career spans over three decades in the biotechnology and molecular diagnostics sectors. Currently, he serves as the Director of Scientific Affairs at Becton Dickinson and Company, focusing on integrated diagnostic solutions for womenโ€™s health, particularly cervical cancer screening. His past roles include R&D leadership at QIAGEN and Corning Incorporated, where he made significant advancements in molecular assay development and product support.

๐ŸŒŸ Contributions and Research Focus

Dr. Vaughan has led teams in developing groundbreaking products such as the BD Onclarity cervical cancer screening test, which received CE Mark approval in 2014 and US-PMA approval in 2018. He has authored content for international conferences and peer-reviewed publications, emphasizing his commitment to advancing scientific knowledge and product innovation in the diagnostics field.

๐ŸŒ Impact and Influence

His work has not only shaped diagnostic guidelines but has also influenced industry standards, as seen with the American Society for Colposcopy and Cervical Pathology (ASCCP) management guidelines launched in 2020. Dr. Vaughan’s expertise is recognized internationally, making him a sought-after speaker at various conferences.

๐Ÿ“š Academic Cites

Dr. Vaughan has made notable contributions to the field of vaccinology, evidenced by multiple patents and publications. His editorial experience as the Editor-in-Chief of “Diseases of Aquatic Organisms” from 1995 to 1999 further underscores his leadership in academic discourse.

๐Ÿ”ง Technical Skills

Dr. Vaughan possesses extensive technical skills in molecular biology, microbiology, and genetics. His proficiency in managing clinical trials, particularly in the R&D lead for Onclarity HPV clinical trials, highlights his ability to oversee complex scientific projects.

๐Ÿ‘ฉโ€๐Ÿซ Teaching Experience

Throughout his career, Dr. Vaughan has demonstrated a passion for education and mentorship. He has developed and delivered training for global customers and internal teams, showcasing his strong communication and interpersonal skills.

๐Ÿ… Legacy and Future Contributions

Dr. Vaughan’s legacy includes a robust portfolio of innovations and leadership in the biotech field. His achievements, such as the Becton Dickinson Wesley J. Howe Award for Technological Innovation in 2013, reflect his dedication to advancing science and technology. Looking ahead, he aims to continue contributing to the development of effective diagnostic solutions and vaccines, focusing on emerging health challenges.

 

๐Ÿ“– Top Noted Publications

Variables that impact HPV test accuracy during vaginal self collection workflow for cervical cancer screening

Authors: Vaughan, L., Gary, D., Shah, M., Galbraith, L., Parvu, V.
Journal: Gynecologic Oncology Reports
Year: 2024

Risk stratification of HPV-positive results using extended genotyping and cytology: Data from the baseline phase of the Onclarity trial

Authors: Stoler, M.H., Parvu, V., Yanson, K., Andrews, J., Vaughan, L.
Journal: Gynecologic Oncology
Year: 2023

Validation of a New High-Throughput BD COR System Using the BD CTGCTV2 Assay

Authors: Taylor, S., Rucki, A., Lockamy, E., Vaughan, L., Greene, W.
Journal: Journal of Molecular Diagnostics
Year: 2022

Evaluation of the Onclarity HPV assay on the high-throughput COR system

Authors: Taylor, S.N., Eckert, K., Rucki, A.A., Vaughan, L.M., Greene, W.H.
Journal: Expert Review of Molecular Diagnostics
Year: 2021

Cotesting in cervical cancer screening

Authors: Malinowski, D.P., Broache, M., Vaughan, L., Andrews, J., Gary, D.
Journal: American Journal of Clinical Pathology
Year: 2021

Analytical and clinical sample performance characteristics of the onclarity assay for the detection of human papillomavirus

Authors: Young, S., Vaughan, L., Yanson, K., Cooper, C.K., van der Pol, B.
Journal: Journal of Clinical Microbiology
Year: 2021